Pro Medicus Limited (ASX: PME)

Pro Medicus Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	60.65	44.44	30.85	23.08	19.13
Depreciation & Amortization	7.93	7.32	7.2	7.68	0.19
Share-Based Compensation	1.23	0.03	0.68	0.65	0.78
Other Operating Activities	-5.03	10.44	0.29	0.19	4.56
Operating Cash Flow	64.77	62.23	39.02	31.59	24.66
Operating Cash Flow Growth	4.09%	59.47%	23.51%	28.12%	77.74%
Capital Expenditures	-6.45	-9.02	-7.69	-7.87	-0.34
Acquisitions	7.26	16.67	0	0	0
Change in Investments	-39.16	-21.26	-19.7	-	-
Other Investing Activities	28.55	-3.95	-	-	-6.96
Investing Cash Flow	-9.8	-17.56	-27.4	-7.87	-7.31
Dividends Paid	-26.11	-18.79	-13.55	-10.92	-9.84
Common Stock Issued	1.42	4.53	0	1.4	0
Share Repurchases	-0.85	-4.02	0	-0.84	0
Other Financing Activities	-3.68	-13.07	-0.5	-3.64	-
Financing Cash Flow	-27.53	-23.31	-14.05	-12.32	-9.84
Net Cash Flow	27.59	21.62	-1.37	11.1	7.08
Free Cash Flow	58.33	53.2	31.33	23.72	24.32
Free Cash Flow Growth	9.63%	69.83%	32.06%	-2.45%	78.09%
Free Cash Flow Margin	46.70%	56.92%	46.15%	41.75%	48.53%
Free Cash Flow Per Share	0.56	0.51	0.30	0.23	0.23

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.